Stocksigma LogoStocksigma Logo

Sagility Delivers Strong Q2 FY27 Results; Approves Interim Dividend and Chirok Health Acquisition

Sagility Limited reported consolidated Q2 FY27 revenue growth of 22.5% YoY (12.2% in constant currency) to ₹20,321 million, driven by a 24.4% YoY rise in

Sagility Delivers Strong Q2 FY27 Results; Approves Interim Dividend and Chirok Health Acquisition

Sagility Ltd · Outcome · 22 Oct 2026, 11:55 pm

Sagility Delivers Strong Q2 FY27 Results; Approves Interim Dividend and Chirok Health Acquisition Sagility Limited reported consolidated Q2 FY27 revenue growth of 22.5% YoY (12.2% in constant currency) to ₹20,321 million, driven by a 24.4% YoY rise in its Payer vertical. Adjusted EBITDA increased 23.0% YoY to ₹5,353 million with margins at 26.3%, while reported PAT reached ₹2,842.12 million (up 13.3% YoY). The company agreed to acquire US-based Chirok Health for $32.35 million to boost provider RCM capabilities and declared an interim dividend of ₹0.15 per share (record date 30th Oct'26).

Original exchange filing (PDF)

More announcements from Sagility Ltd

All Sagility Ltd announcements